Search Results for "Wockhardt Europe Ltd"

11:24 EST 18th December 2014 | BioPortfolio

Matching Channels


The Scandinavian country of Sweden is home to a thriving biotechnology industry, one of the top 5 in Europe. Europe has become a global center for the industry, helped by €2 billion worth of fu...


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...


AA amyloidosis affects approximately 35,000 - 50,000 individuals in the United States, Europe (Top 5 countries) and Japan. The disease occurs in a subset of patients with long-lasting inflammatory c...


At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...

Phoenix MarCom

Phoenix MarCom is a specialist marketing communications company, working with clients in the clean tech (including renewables, environmental technology, low carbon and sustainability), scientific an...

Matching News

Wockhardt Raids Competitors To Deal With Quality-Production Problems

Wockhardt has responded to a series of largely U.S. FDA actions potentially crippling its ability to sell into the vital U.S. market by replacing much of its management with people attracted from Indi...

Rebound Making Wockhardt An Acquisition Target?

Despite its problems with the U.S. FDA, Wockhardt appears to have rebounded to the extent that it may have made itself a possible acquisition target, including by its fellow Indian drug maker, Lupin.

Wockhardt Again Recalls Blood Pressure Drug In U.S.

For the third time in four months, Wockhardt has recalled its metoprolol generic of AstraZeneca's Toprol for treating high blood pressure, again for failing dissolution tests.

Lupin Says Looked At Wockhardt, But No Acquisition Talks

Lupin acknowledges it has looked into the possibility of acquiring troubled Wockhardt, but says the interest has gone no farther than that and the two India drug makers are not in talks.

Wockhardt Limited - Company Capsule

Recently added to the BioPortfolio report store, Wockhardt Limited - Company Capsule is a new report from ICD Research published on 2011-11-16. This 33-page report is available from $75. ICD Resear...

India's Wockhardt Q2 profit plunges on U.S. export bans

MUMBAI, Nov 3 (Reuters) - Indian generic drugmaker Wockhardt Ltd reported a 97 percent drop in quarterly net profit, as regulatory bans on the company's manufacturing plants in India due to poor produ...

Indian drugmaker Wockhardt Q1 net profit plunges 94 pct on plant bans

MUMBAI, Aug 12 (Reuters) - Indian generic drugmaker Wockhardt Ltd on Tuesday said its quarterly net profit plunged 94 percent, as U.S. Food and Drug Administration bans on its manufacturing plants con...

Wockhardt Drug Gets India's First U.S. QIDP Fast-Track Status

Wockhardt has become the first India drug maker to receive U.S. FDA Qualified Infectious Disease Product status, a fast-track review designation, for two versions of its anti-MRSA drug.

Matching PubMed Articles

Treatment and care of TB across Europe.

There continues to be profound differences in TB incidences as well as in TB treatment and care across Europe in recent years. High TB incidences are observed in Eastern Europe and especially among in...

Maritime route of colonization of Europe.

The Neolithic populations, which colonized Europe approximately 9,000 y ago, presumably migrated from Near East to Anatolia and from there to Central Europe through Thrace and the Balkans. An alternat...

Inequality in the long run.

This Review presents basic facts regarding the long-run evolution of income and wealth inequality in Europe and the United States. Income and wealth inequality was very high a century ago, particularl...

Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America.

Introduction: Rates of both TB/HIV co-infection and multi-drug-resistant (MDR) TB are increasing in Eastern Europe (EE). Data on the clinical management of TB/HIV co-infected patients are scarce. Our ...

Hypoglycin A Concentrations in Seeds of Acer Pseudoplatanus Trees Growing on Atypical Myopathy-Affected and Control Pastures.

Hypoglycin A, found in seeds of Acer negundo, appears to cause seasonal pasture myopathy (SPM) in North America and is implicated in atypical myopathy (AM) in Europe. Acer negundo is uncommon in Europ...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement